Regen BioPharma Inc (RGBP)

[Goldstrike]

The future value of NR2F6 is to be determined. We do know the time and cost required to bring a therapy to market, which RGBP is not equipped to do.

Koots is probably going for a buyout of some kind. Unless some miracle occurs, I think the pps will be in the.20 to .30 range.

Be careful of Koots and be aware of his record. HemaXellerate was cleared for clinical trials but went nowhere.

Another therapy had clinical trials that took place in Tijuana (no shit).

Then on the Zander spin-off he introduced a therapy for dogs that combined NR2F6 with CBD. That's when I lost it with Koots.

Remember, he'll milk this for what it's worth. Hope for some trickle down.

Meanwhile, thar she blows...